Lacmoid

Lacmoid

SCHEMBL2609260

O=c1cc2oc3cc(O)c(-c4ccc(O)cc4O)cc3nc-2cc1-c1ccc(O)cc1O

nearest known ligand 0.81

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SNCA P37840 1/20 0.81
APP P05067 2/20 0.50
BACE1 P56817 2/20 0.48
TYR P14679 1/20 0.48
PTPN1 P18031 1/20 0.48
PTGS1 P23219 1/20 0.48
PTPN12 Q05209 1/20 0.48
PTPN22 Q9Y2R2 1/20 0.48
KMT2A Q03164 5/20 0.47
HPGD P15428 5/20 0.47
MEN1 O00255 4/20 0.47
KDM4E B2RXH2 4/20 0.47
CYP3A4 P08684 4/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
ESR1 P03372 4/20 0.44
ESR2 Q92731 3/20 0.44
LMNA P02545 3/20 0.42
ALDH1A1 P00352 3/20 0.41
MAPT P10636 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lacmoid SCHEMBL29455251 1.00 SNCA (0.81) SNCAAPPBACE1TYRPTPN1
SCHEMBL13521269 0.93 SNCA (0.71) SNCAAPPBACE1TYRPTPN1
SCHEMBL2609269 0.90 SNCA (1.00) SNCAAPPBACE1TYRPTPN1
SCHEMBL13556902 0.84 SNCA (0.87) SNCAAPPBACE1TYRPTPN1
SCHEMBL13083868 0.78 SNCA (0.54) SNCAAPPPTPN1KMT2AHPGD
SCHEMBL3776968 0.72 ALDH1A1 (0.68) SNCAAPPBACE1TYRPTPN1
SCHEMBL29052306 0.72 MAPT (0.68) SNCAAPPKMT2AHPGDMEN1
SCHEMBL327849 0.72 APP (0.63) SNCAAPPBACE1TYRPTPN1
SCHEMBL12714456 0.70 SNCA (0.47) SNCAAPPKMT2AHPGDMEN1
SCHEMBL12714421 0.70 SNCA (0.47) SNCAAPPKMT2AHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210302442-A1 A FRET-BASED METHOD TO MEASURE SEEDING ACTIVITY OF MISFOLDED PROTEIN SPECIES IN BIOLOGICAL SAMPLES MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT (DE) 2021-09-30 US disclosed
US-8559093-B2 Electrochromic mirror reflective element for vehicular rearview mirror assembly DONNELLY CORPORATION (US) 2013-10-15 US disclosed
US-8559093-B2 Electrochromic mirror reflective element for vehicular rearview mirror assembly DONNELLY CORPORATION (US) 2013-10-15 US disclosed
US-20130063802-A1 VARIABLE TRANSMISSION WINDOW DONNELLY CORPORATION (US) 2013-03-14 US disclosed
US-20130063802-A1 VARIABLE TRANSMISSION WINDOW DONNELLY CORPORATION (US) 2013-03-14 US disclosed
WO-2012136655-A1 PHENOXAZINONES OR PHENOTHIAZONES AS INHIBITORS OF AMYLOID FORMATION Max-Delbrück-Centrum für Molekulare Medizin (DE) 2012-10-11 WO disclosed
EP-2508186-A1 Phenoxazinones or phenothiazones as inhibitors of amyloid formation Max-Delbrück-Centrum für Molekulare Medizin (DE) 2012-10-10 EP disclosed
EP-2508186-A1 Phenoxazinones or phenothiazones as inhibitors of amyloid formation Max-Delbrück-Centrum für Molekulare Medizin (DE) 2012-10-10 EP disclosed
US-20120206790-A1 ELECTROCHROMIC MIRROR REFLECTIVE ELEMENT FOR VEHICULAR REARVIEW MIRROR ASSEMBLY DONNELLY CORPORATION (US) 2012-08-16 US disclosed
US-20120206790-A1 ELECTROCHROMIC MIRROR REFLECTIVE ELEMENT FOR VEHICULAR REARVIEW MIRROR ASSEMBLY DONNELLY CORPORATION (US) 2012-08-16 US disclosed
US-7589883-B2 Vehicular exterior mirror DONNELLY CORPORATION (US) 2009-09-15 US disclosed
US-7589883-B2 Vehicular exterior mirror DONNELLY CORPORATION (US) 2009-09-15 US disclosed
US-20080094685-A1 VEHICULAR EXTERIOR MIRROR DONNELLY CORPORATION (US) 2008-04-24 US disclosed
US-20080094685-A1 VEHICULAR EXTERIOR MIRROR DONNELLY CORPORATION (US) 2008-04-24 US disclosed
US-7349144-B2 Exterior electrochromic reflective mirror element for a vehicular rearview mirror assembly DONNELLY CORPORATION (US) 2008-03-25 US disclosed
US-7349144-B2 Exterior electrochromic reflective mirror element for a vehicular rearview mirror assembly DONNELLY CORPORATION (US) 2008-03-25 US disclosed
US-20070184284-A1 Exterior electrochromic reflective mirror element for a vehicular rearview mirror assembly DONNELLY CORPORATION (US) 2007-08-09 US disclosed
US-20070184284-A1 Exterior electrochromic reflective mirror element for a vehicular rearview mirror assembly DONNELLY CORPORATION (US) 2007-08-09 US disclosed
US-7202987-B2 Electrochromic polymeric solid films, manufacturing electrochromic devices using such solid films, and processes for making such solid films and devices DONNELLY CORPORATION (US) 2007-04-10 US disclosed
US-7202987-B2 Electrochromic polymeric solid films, manufacturing electrochromic devices using such solid films, and processes for making such solid films and devices DONNELLY CORPORATION (US) 2007-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210302442-A1 A FRET-BASED METHOD TO MEASURE SEEDING ACTIVITY OF MISFOLDED PROTEIN SPECIES IN BIOLOGICAL SAMPLES HTT, APBA1, HSPBP1 SNCA 101/4885APP 7/4885BACE1 59/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.